MedTrace Logo

Transdermal Radiofrequency V ERASER Versus Polidocanol Sclerotherapy for Reticular Veins and Telangiectasias

NCT06962813 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 46

Last updated 2025-05-08

No results posted yet for this study

Summary

This study tested V Eraser, Transdermal radiofrequency versus polidocanol sclerotherapy for the treatment of reticular veins and telangiectasia of the legs

Conditions

  • Varicose Veins Leg
  • Telangiectasias

Interventions

PROCEDURE

Radiofrequency V Eraser

standar of care sclerotherapy

Sponsors & Collaborators

  • Science Valley Research Institute

    lead OTHER

Principal Investigators

  • Rebeca Higino, MD · Faculty of Medical Sciences of Santa Casa de São Paulo

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-01-10
Primary Completion
2025-01-02
Completion
2025-04-10

Countries

  • Brazil

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06962813 on ClinicalTrials.gov